Form D · Other
Longevix, Inc.
New York, NY · CIK 0002015928
Offering snapshot reported Nov 27, 2024 · SEC filing
- Reported sold
- $550K Offering amount: $2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 14, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 27, 2024 | Initial | $550,000 | No comparison | 2 | SEC filing |
| Mar 27, 2024 | Initial | $450,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530635
Source: Form D, filed Nov 27, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrei Zimiles | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
200 W. 67 Th Apt 41 A
New York, NY, 10023
New York, NY, 10023